{"id":"https://openalex.org/W4387747238","doi":"https://doi.org/10.1016/j.japh.2023.10.014","title":"Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains","display_name":"Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains","publication_year":2023,"publication_date":"2023-10-18","ids":{"openalex":"https://openalex.org/W4387747238","doi":"https://doi.org/10.1016/j.japh.2023.10.014","pmid":"https://pubmed.ncbi.nlm.nih.gov/37863398","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11014459"},"language":"en","primary_location":{"id":"doi:10.1016/j.japh.2023.10.014","doi":"https://doi.org/10.1016/j.japh.2023.10.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.japh.2023.10.014","pdf_url":"http://www.japha.org/article/S1544319123003217/pdf","source":{"id":"https://openalex.org/S4210228861","display_name":"Journal of the American Pharmacists Association","issn_l":"1544-3191","issn":["1544-3191","1544-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of the American Pharmacists Association","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.japha.org/article/S1544319123003217/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011399310","display_name":"Traci  Craig Green","orcid":"https://orcid.org/0000-0001-9105-6904","observed_orcids":["https://orcid.org/0000-0001-9105-6904","https://orcid.org/0000-0002-7924-7000"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]},{"id":"https://openalex.org/I6902469","display_name":"Brandeis University","ror":"https://ror.org/05abbep66","country_code":"US","type":"education","lineage":["https://openalex.org/I6902469"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Traci C. Green","raw_affiliation_strings":["Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA and the Departments of Emergency Medicine and Epidemiology, Brown Schools of Medicine and Public Health, Providence, RI USA"],"raw_orcid":"https://orcid.org/0000-0001-9105-6904","affiliations":[{"raw_affiliation_string":"Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA and the Departments of Emergency Medicine and Epidemiology, Brown Schools of Medicine and Public Health, Providence, RI USA","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I6902469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090306381","display_name":"Joseph Silcox","orcid":"https://orcid.org/0000-0003-2207-3457","observed_orcids":["https://orcid.org/0000-0003-2207-3457"]},"institutions":[{"id":"https://openalex.org/I6902469","display_name":"Brandeis University","ror":"https://ror.org/05abbep66","country_code":"US","type":"education","lineage":["https://openalex.org/I6902469"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Silcox","raw_affiliation_strings":["Policy Research Collaborative , Heller School for Social Policy and Manage- ment , Brandeis University , 415 South St. , MS035 , Heller-Brown Bldg. , Wal- tham , MA 02453","Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA USA"],"raw_orcid":"https://orcid.org/0000-0003-2207-3457","affiliations":[{"raw_affiliation_string":"Policy Research Collaborative , Heller School for Social Policy and Manage- ment , Brandeis University , 415 South St. , MS035 , Heller-Brown Bldg. , Wal- tham , MA 02453","institution_ids":["https://openalex.org/I6902469"]},{"raw_affiliation_string":"Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA USA","institution_ids":["https://openalex.org/I6902469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087198776","display_name":"Derek Bolivar","orcid":"https://orcid.org/0000-0002-2947-0204","observed_orcids":["https://orcid.org/0000-0002-2947-0204"]},"institutions":[{"id":"https://openalex.org/I6902469","display_name":"Brandeis University","ror":"https://ror.org/05abbep66","country_code":"US","type":"education","lineage":["https://openalex.org/I6902469"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Derek Bolivar","raw_affiliation_strings":["Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA USA"],"raw_orcid":"https://orcid.org/0000-0002-2947-0204","affiliations":[{"raw_affiliation_string":"Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA USA","institution_ids":["https://openalex.org/I6902469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009074913","display_name":"Mary Tod Gray","orcid":"https://orcid.org/0000-0001-5841-4095","observed_orcids":["https://orcid.org/0000-0001-5841-4095"]},"institutions":[{"id":"https://openalex.org/I4210093664","display_name":"Comagine Health","ror":"https://ror.org/007476v46","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210093664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Gray","raw_affiliation_strings":["Comagine Health, Portland, OR USA"],"raw_orcid":"https://orcid.org/0000-0001-5841-4095","affiliations":[{"raw_affiliation_string":"Comagine Health, Portland, OR USA","institution_ids":["https://openalex.org/I4210093664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051985236","display_name":"Anthony S. Floyd","orcid":"https://orcid.org/0000-0002-1063-0132","observed_orcids":["https://orcid.org/0000-0002-1063-0132"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony S. Floyd","raw_affiliation_strings":["Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA USA"],"raw_orcid":"https://orcid.org/0000-0002-1063-0132","affiliations":[{"raw_affiliation_string":"Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068219229","display_name":"Adriane N. Irwin","orcid":"https://orcid.org/0000-0002-2086-4493","observed_orcids":["https://orcid.org/0000-0002-2086-4493"]},"institutions":[{"id":"https://openalex.org/I131249849","display_name":"Oregon State University","ror":"https://ror.org/00ysfqy60","country_code":"US","type":"education","lineage":["https://openalex.org/I131249849"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adriane N. Irwin","raw_affiliation_strings":["Oregon State University College of Pharmacy, Department of Pharmacy Practice, Corvalis, OR USA"],"raw_orcid":"https://orcid.org/0000-0002-2086-4493","affiliations":[{"raw_affiliation_string":"Oregon State University College of Pharmacy, Department of Pharmacy Practice, Corvalis, OR USA","institution_ids":["https://openalex.org/I131249849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078803157","display_name":"Ryan N. Hansen","orcid":"https://orcid.org/0000-0003-3887-1242","observed_orcids":["https://orcid.org/0000-0003-3887-1242"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan N. Hansen","raw_affiliation_strings":["The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA USA"],"raw_orcid":"https://orcid.org/0000-0003-3887-1242","affiliations":[{"raw_affiliation_string":"The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086002607","display_name":"Daniel M. Hartung","orcid":"https://orcid.org/0000-0002-0685-773X","observed_orcids":["https://orcid.org/0000-0002-0685-773X"]},"institutions":[{"id":"https://openalex.org/I131249849","display_name":"Oregon State University","ror":"https://ror.org/00ysfqy60","country_code":"US","type":"education","lineage":["https://openalex.org/I131249849"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel M. Hartung","raw_affiliation_strings":["Oregon State University College of Pharmacy, Department of Pharmacy Practice, Corvalis, OR USA"],"raw_orcid":"https://orcid.org/0000-0002-0685-773X","affiliations":[{"raw_affiliation_string":"Oregon State University College of Pharmacy, Department of Pharmacy Practice, Corvalis, OR USA","institution_ids":["https://openalex.org/I131249849"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019064294","display_name":"Jeffrey P. Bratberg","orcid":"https://orcid.org/0000-0002-2240-5768","observed_orcids":["https://orcid.org/0000-0002-2240-5768"]},"institutions":[{"id":"https://openalex.org/I17626003","display_name":"University of Rhode Island","ror":"https://ror.org/013ckk937","country_code":"US","type":"education","lineage":["https://openalex.org/I17626003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Bratberg","raw_affiliation_strings":["University of Rhode Island College of Pharmacy, South Kingston, RI, USA"],"raw_orcid":"https://orcid.org/0000-0002-2240-5768","affiliations":[{"raw_affiliation_string":"University of Rhode Island College of Pharmacy, South Kingston, RI, USA","institution_ids":["https://openalex.org/I17626003"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5011399310"],"corresponding_institution_ids":["https://openalex.org/I27804330","https://openalex.org/I6902469"],"apc_list":{"value":2630,"currency":"USD","value_usd":2630},"apc_paid":null,"fwci":1.0191,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.75812105,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"64","issue":"1","first_page":"71","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.6553000211715698,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.6553000211715698,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":0.33149999380111694,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/harm-reduction","display_name":"harm reduction","score":0.8880000114440918},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9520000219345093},{"id":"https://openalex.org/keywords/community-pharmacy","display_name":"community pharmacy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.7009999752044678},{"id":"https://openalex.org/keywords/drive-thru-service","display_name":"drive-thru service","score":0.6539999842643738},{"id":"https://openalex.org/keywords/opioid-crisis","display_name":"opioid epidemic","score":0.6990000009536743},{"id":"https://openalex.org/keywords/pharmacy-chains","display_name":"pharmacy chains","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.877670407295227},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7462759017944336},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.6469157934188843},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.6408931016921997},{"id":"https://openalex.org/C529928208","wikidata":"https://www.wikidata.org/wiki/Q1458711","display_name":"Harm reduction","level":3,"score":0.555797815322876},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.48066937923431396},{"id":"https://openalex.org/C2778571141","wikidata":"https://www.wikidata.org/wiki/Q273318","display_name":"Syringe","level":2,"score":0.4355964660644531},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.40571683645248413},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.3672049045562744},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.19458922743797302},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.18392175436019897},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.17228537797927856},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.09244102239608765},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003157","descriptor_name":"Community Pharmacy Services","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004366","descriptor_name":"Nonprescription Drugs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010594","descriptor_name":"Pharmacies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010604","descriptor_name":"Pharmacy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058873","descriptor_name":"Pandemics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.japh.2023.10.014","doi":"https://doi.org/10.1016/j.japh.2023.10.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.japh.2023.10.014","pdf_url":"http://www.japha.org/article/S1544319123003217/pdf","source":{"id":"https://openalex.org/S4210228861","display_name":"Journal of the American Pharmacists Association","issn_l":"1544-3191","issn":["1544-3191","1544-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of the American Pharmacists Association","raw_type":"journal-article"},{"id":"pmid:37863398","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37863398","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Pharmacists Association : JAPhA","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11014459","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11014459","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11014459/pdf/nihms-1960121.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Am Pharm Assoc (2003)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.japh.2023.10.014","doi":"https://doi.org/10.1016/j.japh.2023.10.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.japh.2023.10.014","pdf_url":"http://www.japha.org/article/S1544319123003217/pdf","source":{"id":"https://openalex.org/S4210228861","display_name":"Journal of the American Pharmacists Association","issn_l":"1544-3191","issn":["1544-3191","1544-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of the American Pharmacists Association","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5648572831","display_name":"Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial","funder_award_id":"R01DA045745","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7402906800","display_name":null,"funder_award_id":"NCT03545321","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387747238.pdf","grobid_xml":"https://content.openalex.org/works/W4387747238.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W3020359399","https://openalex.org/W3035173223","https://openalex.org/W3158655420","https://openalex.org/W3171267080","https://openalex.org/W3211927912","https://openalex.org/W4200534390","https://openalex.org/W4214769197","https://openalex.org/W4220710316","https://openalex.org/W4285602131","https://openalex.org/W4286887151","https://openalex.org/W4291475213","https://openalex.org/W4292261915","https://openalex.org/W4306320889","https://openalex.org/W4310817975","https://openalex.org/W4313416133","https://openalex.org/W4317900445","https://openalex.org/W4318204043","https://openalex.org/W6796857980"],"related_works":["https://openalex.org/W4306320889","https://openalex.org/W3184393304","https://openalex.org/W4400831215","https://openalex.org/W4318204043","https://openalex.org/W6981790716","https://openalex.org/W4391735903","https://openalex.org/W2990569977","https://openalex.org/W3176642569","https://openalex.org/W3080116452","https://openalex.org/W7160580944"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-10-19T00:00:00"}